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Saudi Arabia and identify the rate of primary and sec-
ondary pulmonary hypertension among pediatric
patients with Down syndrome. Cross-sectional, retro-
spective study of the cardiac anomalies among 331 pedia-
tric patients (0–18 years) with Down Syndrome in King
Khalid University Hospital (KKUH) from August 2001 till
October 2014. The demographic data, reason for referral,
echocardiography data including systolic function para-
meters, the presence of CHD, type and details of CHD,
presence of pulmonary hypertension (PHTN), history of
cardiac surgeries or transcatheter interventions. Among
the 331 pediatric patients with Down Syndrome; 230
patients (69.5%) have Congenital Heart Defect (CHD).
The patients with CHD were significantly younger (med-
ian age 3 months) with lower weight (P-value <0.05) and
height (P-value <0.05) compared to patients with no
CHD. The median age at first assessment was 3 months.
The most common type of CHDs among DS pediatric
patients was atrial septal defect secundum (ASD II)
which account for 33.5% of all CHD followed by ventricu-
lar septal defect (VSD) which account for 26.5%, then
atrioventricular septal defect (AVSD) 21.7% and moder-
ate to large patent ductus arteriosus (PDA) 21.7%. There
is another (11.7%) who have other CHDs. Pulmonary
hypertension was present in 32% of patients with CHD
vs 4% among patients with no CHD. There is significant
relationship between CHD and pulmonary hypertension
with odds ratio 11.3 (CI 3.99–31.83, P-value <0.05). 15% of
patients underwent either cardiac surgery or transcath-
eter intervention. Almost two thirds of Down Syndrome
patients have CHD with pulmonary hypertension affect-
ing almost one third of patients with CHD. The most
common CHD among Down Syndrome patients were
ASD, VSD, AVSD and moderate to large PDA. Early
detection is required to facilitate early management and
prevent complications manage patients and preform
early interventions as appropriate.
http://dx.doi:10.1016/j.jsha.2016.04.077
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Ultrasound (US) assessment of renal anomalies in
children requiring pediatric cardiac surgery is not a stan-
dard practice. This study aimed to study the role of bed-
side US performed by intensivists to detect occult renal
anomalies associated with congenital heart disease
(CHD). Prospective descriptive study for 100 consecutive
children with CHD admitted to Pediatric Cardiac Inten-
sive Care Unit (PCICU) from Januarry 1st, 2015 through
June, July 2015. Ultrasound of kidneys was performed
initially by trained pediatric cardiac intensivists to ascer-
tain the presence of both kidneys in renal fossae and to
check for gross kidney anomalies. After screening of
100 consecutive children with CHD with renal US, we
identified in 94 cases (94%) normal right and left kidney
in the standard sonographer shape in the renal fossae.
In 6 cases further investigation revealed ectopic kidney
in 3 patients (50%), solitary functional kidney in 2
patients (33.4%) and bilateral grade IV hydronephrosis
in one patient (16.6%). Urinary tract infection developed
peri-operatively in 66% of the cases with kidney anoma-
lies. No significant renal impairment was noted in these
patients post-surgery. We observed no specific associa-
tion between the type of renal anomaly and specific
CHD. Renal US in children with CHD demonstrated pre-
valence of associated congenital renal anomalies in 6% of
children undergoing cardiac surgery. The presence of
occult kidney anomalies did not impact the kidney func-
tion or the short term outcome after cardiac repair except
for an increased risk of urosepsis. Performing renal US
should be a standard practice in all children with CHD.
http://dx.doi:10.1016/j.jsha.2016.04.078
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Objectives: The Arab world covers a vast geographic
area, consisting of 23 countries with a combined popula-
tion of about 358 million people. Geographically, this part
of the globe is variable ranging from dry desert areas to
heavily raining green land. It is unique for its wide cul-
tural, social, ethnic variations and in pattern of health
and disease. The rapid economical changes in Middle
East attract large number of people to the metropolitan
cities of Middle East especially the Gulf Cooperation
Council (GCC) countries. The urban areas of Middle East
are facing challenges of air pollution driven by industria-
lization and rapidly growing vehicle fleets. The aim of
this study was to investigate the effects of air pollution
on coronary artery disease.
Material and methods: In this study, we identified 72
published studies through a systematic database
searches including ISI-web of science and pub-med.
We searched the related literature by using the key
words including environmental pollution, coronary
artery disease. All studies in which environmental pollu-
tion and coronary artery disease was investigated were
included in the study. No limitations on publication sta-
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tus, study design or language of publication were imple-
mented. Finally, we included 52 publications and remain-
ing 20 were excluded from the study.
Results: Environmental pollution exert their detrimen-
tal effects on heart by developing pulmonary inflamma-
tion, systemic inflammation, enhanced coagulation,
thrombosis, acute arterial vasoconstriction, atherosclero-
sis and coronary artery disease.
Conclusion: Environmental pollution exert detrimental
effects on the heart. The researchers and physicians must
consider the environmental pollution as an emerging fac-
tor in the development of coronary artery disease.
http://dx.doi:10.1016/j.jsha.2016.04.079
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Diabetes is a highly prevalent chronic disease world-
wide. It was observed inKing Abdul-Aziz Cardiac Centre
(KACC) that, subjects treated with basal bolus insulin
showed better glycemic control than premixed insulin.
Aim: To compare the efficacy and safety of basal-bolus
insulin, to premixed insulin in subjects with type 2 dia-
betes. Retrospective, comparison, chart review study
included all subjects with type 2 diabetes in KACC fol-
lowed up in the Cardiac Diabetes Clinic, between 2010
and 2015, who are treated with basal bolus insulin or pre-
mixed insulin. Data including HbA1C, body weight, and
hypoglycemia events, pre and 1 year post initiation of
insulin therapy, will be extracted from all subject’s med-
ical records. Results will be compared between the two
groups and analyzed using SPSS. Data for 400 patients
was collected and analyzed. Patients were divided into
two groups, Group (A) who received premixed Insulin
70/30 and Group (B) which included all patients who
received Basal Bolus Insulin (N 170). Group A included
230 patients, 72% of subject in this group were Female
with mean age of 64 years (STD 10), with mean HbA1c
of 9.6% pre insulin use compared to 9.1% one year later
(p 0.001). Group (B) included 170 patients with 64% of
them were male with mean age of 61 (STD 12), with mean
HbA1c of 9.9% before the use of Basal bolus insulin com-
pared to 9.1% one year later (p 0.001). However there was
no significant difference in the effect of Premixed insulin
compared to Basal Bolus insulin on HbA1c. The use of
either Basal Bolus insulin or Premixed has similar signif-
icant effect on HbA1c.
http://dx.doi:10.1016/j.jsha.2016.04.080
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Background: The characteristics and outcomes of heart
failure (HF) patients have been described by numerous
studies worldwide. However very limited information is
available about Saudi HF patients.
Aim: To determine the general characteristics, treat-
ment, and outcomes of Saudi patients with the diagnosis
of HF followed up in a Nurse-Led Cardiovascular Dis-
ease Management Program (CVDMP) in King Abdulaziz
Cardiac Centre (KACC). This is a retrospective chart
review study, that included all HF who are followed up
in KACC/CVDMP over the time period from 2000 to
2015. Data extracted from the cardiac electronic data base
(Apollo) for all patients who have at least 2 visits; enroll-
ment (EV) and last follow up (LV). A total of 2298 patients
(72% Male, mean age 58 STD 12.7 years) included in this
study. Ischemic cardiomyopathy presented in 60% of
patients, diabetes mellitus in 66%, dyslipidemia in 76%
and 64% of patients were hypertensive. Majority of
patients had both Systolic and Diastolic HF (70%), with
stage C HF in EV and LV. Avarage EF improved from
32% to 38% (P 0.0001). Over 90% of the patients were
on ACE, ARBs or the combination during EV and LV.
Overall mortality was 12.1%. Saudi heart failure patients
are relatively younger with higher prevalence of cardiac
risk factors. These patients are treated as per Guideline
recommended therapy.
http://dx.doi:10.1016/j.jsha.2016.04.081
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